» Articles » PMID: 33442000

Enhancer Redundancy in Development and Disease

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2021 Jan 14
PMID 33442000
Citations 100
Authors
Affiliations
Soon will be listed here.
Abstract

Shadow enhancers are seemingly redundant transcriptional cis-regulatory elements that regulate the same gene and drive overlapping expression patterns. Recent studies have shown that shadow enhancers are remarkably abundant and control most developmental gene expression in both invertebrates and vertebrates, including mammals. Shadow enhancers might provide an important mechanism for buffering gene expression against mutations in non-coding regulatory regions of genes implicated in human disease. Technological advances in genome editing and live imaging have shed light on how shadow enhancers establish precise gene expression patterns and confer phenotypic robustness. Shadow enhancers can interact in complex ways and may also help to drive the formation of transcriptional hubs within the nucleus. Despite their apparent redundancy, the prevalence and evolutionary conservation of shadow enhancers underscore their key role in emerging metazoan gene regulatory networks.

Citing Articles

Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X Cell Death Discov. 2025; 11(1):84.

PMID: 40032852 PMC: 11876437. DOI: 10.1038/s41420-025-02366-3.


Interplay between CTCF-binding and CTCF-lacking regulatory elements in generating an architectural stripe at the Igh locus.

Ma F, Ollikainen N, Du H, Braikia F, Cui N, Bianchi A Nat Commun. 2025; 16(1):2148.

PMID: 40032827 PMC: 11876664. DOI: 10.1038/s41467-025-57373-w.


Comprehensive dissection of cis-regulatory elements in a 2.8 Mb topologically associated domain in six human cancers.

Caragine C, Le V, Mustafa M, Diaz B, Morris J, Muller S Nat Commun. 2025; 16(1):1611.

PMID: 39948336 PMC: 11825950. DOI: 10.1038/s41467-025-56568-5.


Genetic coupling of enhancer activity and connectivity in gene expression control.

Ray-Jones H, Sung C, Chan L, Haglund A, Artemov P, Della Rosa M Nat Commun. 2025; 16(1):970.

PMID: 39870618 PMC: 11772589. DOI: 10.1038/s41467-025-55900-3.


A cardiac transcriptional enhancer is repurposed during regeneration to activate an anti-proliferative program.

Rao A, Russell A, Segura-Bermudez J, Franz C, Dockery R, Blatnik A Development. 2025; 152(4).

PMID: 39803985 PMC: 11883283. DOI: 10.1242/dev.204458.


References
1.
Shlyueva D, Stampfel G, Stark A . Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet. 2014; 15(4):272-86. DOI: 10.1038/nrg3682. View

2.
Furlong E, Levine M . Developmental enhancers and chromosome topology. Science. 2018; 361(6409):1341-1345. PMC: 6986801. DOI: 10.1126/science.aau0320. View

3.
Long H, Prescott S, Wysocka J . Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution. Cell. 2016; 167(5):1170-1187. PMC: 5123704. DOI: 10.1016/j.cell.2016.09.018. View

4.
Schoenfelder S, Fraser P . Long-range enhancer-promoter contacts in gene expression control. Nat Rev Genet. 2019; 20(8):437-455. DOI: 10.1038/s41576-019-0128-0. View

5.
Andersson R, Sandelin A . Determinants of enhancer and promoter activities of regulatory elements. Nat Rev Genet. 2019; 21(2):71-87. DOI: 10.1038/s41576-019-0173-8. View